World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
59
Citations
8652
World Ranking
3351
National Ranking
96

David W. Scheifele publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David W. Scheifele sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 236 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David W. Scheifele D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David W. Scheifele sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 59 D-Index — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David W. Scheifele is a researcher affiliated with the University of British Columbia in Canada, specializing in medical and immunological studies. Their work spans several fields including medicine and immunology and microbiology, with a particular focus on epidemiology, microbiology, immunology, surgery, and biomedical engineering.

The scientist's research covers multiple topics, notably bacterial infections and vaccines, pneumonia and respiratory infections, Kawasaki disease and coronary complications, mechanical circulatory support devices, influenza virus research studies, immune responses and vaccinations, and hepatitis B virus studies.

Frequent publication venues for their research include Human Vaccines & Immunotherapeutics, Emerging Infectious Diseases, Research Square, and Paediatrics & Child Health.

Recent papers authored or co-authored by David W. Scheifele include:

  • Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018, 2022, Human Vaccines & Immunotherapeutics
  • Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada, 2020, Emerging Infectious Diseases
  • Modeling a BCG Birth Dose-based Vaccination Program for Improved Hepatitis B Control in Uganda: Mixed-methods study, 2022, Research Square
  • Streptococcus pneumoniae-associated hemolytic uremic syndrome Canadian Immunization Monitoring Program ACTive National Pediatric Surveillance (1991 to 2019), 2024, Paediatrics & Child Health

Collaborations are a significant aspect of their research. Frequent co-authors include Julie A. Bettinger, Scott A. Halperin, Manish Sadarangani, Taj Jadavji, and Cora Constantinescu.

Best Publications

  • Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

    Simon R. M. Dobson;Shelly McNeil;Marc Dionne;Meena Dawar

  • Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary-Area Streptococcus pneumoniae Research (CASPER) Study

    James D. Kellner;Otto G. Vanderkooi;Otto G. Vanderkooi;Judy MacDonald;Judy MacDonald;Deirdre L. Church

  • Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991- 1997: Report of the Immunization Monitoring Program—Active (IMPACT)

    Scott A. Halperin;Elaine E. L. Wang;Barbara Law;Elaine Mills

  • Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada.

    Lynda K Mikelova;Scott A Halperin;David Scheifele;Bruce Smith

  • Maternal immunisation: collaborating with mother nature.

    Arnaud Marchant;Manish Sadarangani;Manish Sadarangani;Mathieu Garand;Mathieu Garand;Nicolas Dauby

  • School-based hepatitis B vaccination programme and adolescent multiple sclerosis.

    A Dessa Sadovnick;David W Scheifele

  • Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

    Raymond H. See;Alexander N. Zakhartchouk;Martin Petric;David J. Lawrence

  • Hospitalization for Influenza A Versus B.

    Dat Tran;Wendy Vaudry;Dorothy Moore;Julie A Bettinger

  • The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

    Julie A. Bettinger;David W. Scheifele;James D. Kellner;Scott A. Halperin

  • Decrease in Hospital Admissions for Febrile Seizures and Reports of Hypotonic-Hyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular Pertussis Vaccine in Canada: A Report From IMPACT

    Nicole Le Saux;Nicholas J Barrowman;Dorothy L Moore;Sharon Whiting

  • Assessment of a universal, school-based hepatitis B vaccination program.

    Simon Dobson;David Scheifele;Alison Bell

  • Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004.

    Dorothy L. Moore;Wendy Vaudry;David W. Scheifele;Scott A. Halperin

  • Pertussis and influenza immunisation during pregnancy: a landscape review

    Bahaa Abu Raya;Kathryn M Edwards;David W Scheifele;Scott A Halperin

  • Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis

    Unknown

  • Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.

    Athena McConnell;Ben Tan;David Scheifele;Scott Halperin

  • Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

    Scott A. Halperin;Bruce Smith;Margaret Russell;David Scheifele

  • Cross-reactive and Vaccine-Induced Antibody to an Emerging Swine-Origin Variant of Influenza A Virus Subtype H3N2 (H3N2v)

    Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Dale Purych

  • Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).

    Julie A. Bettinger;David W. Scheifele;Scott A. Halperin;Wendy Vaudry

  • Progress in the prevention of pneumococcal infection

    James D. Kellner;Deirdre L. Church;Judy MacDonald;Gregory J. Tyrrell

  • Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.

    James D. Kellner;David Scheifele;Otto G. Vanderkooi;Judy MacDonald

  • Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis.

    Unknown

  • Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.

    Gordean Bjornson;David W. Scheifele;Julie Bettinger;David M. Patrick

Frequent Co-Authors

Scott A. Halperin
Scott A. Halperin Dalhousie University
Brian J. Ward
Brian J. Ward McGill University Health Centre
Gaston De Serres
Gaston De Serres Université Laval
Marc Dionne
Marc Dionne Université Laval
Yan Li
Yan Li Public Health Agency of Canada
Shelly A. McNeil
Shelly A. McNeil Dalhousie University
Danuta M. Skowronski
Danuta M. Skowronski University of British Columbia
Tobias R. Kollmann
Tobias R. Kollmann Dalhousie University
Mel Krajden
Mel Krajden University of British Columbia
Natasha S. Crowcroft
Natasha S. Crowcroft University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths and educational opportunities. For those interested in healthcare, becoming a child specialist salary can be a rewarding choice, blending scientific knowledge with patient care. This role often requires specialized training that complements a microbiology background.

Individuals with unique challenges or records may find programs tailored to their needs as well. Exploring the best associate degrees for felons highlights accessible education paths that can lead to stable careers, with many online options providing flexibility and support.

With the rise of holistic and preventive health, careers like a how to become a functional medicine nurse practitioner appeal to those wanting to apply microbiological insights in clinical settings. These roles merge traditional knowledge with innovative practices to improve patient outcomes.

Another notable pathway is becoming a certified professional coder, which plays a crucial role in healthcare administration. This career benefits from detail-oriented individuals with a strong understanding of medical terminology and coding systems, many of which intersect with microbiology studies.

Best Scientists Citing David W. Scheifele

Trending Scientists

Recently Published Articles